Clinical Trials
Note: This document is prepared as a service for the ALS community and is intended as general information. Content used in this report is obtained from informed members of the pharmaceutical industry and the ALS community.
For further information on drug trials, ClinicalTrials.gov provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions. For an overview of clinical trials information, click here.
OPEN TRIALS
Compound or Trial
Status & Sites
Company or Center
Note: This document is prepared as a service for the ALS community and is intended as general information. Content used in this report is obtained from informed members of the pharmaceutical industry and the ALS community.
For further information on drug trials, ClinicalTrials.gov provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions. For an overview of clinical trials information, click here.
OPEN TRIALS
Compound or Trial
Status & Sites
Company or Center
Validation of ALS Biomarkers
New Enrolling
Multi-center
Talampanel
Now Enrolling
Teva Pharmaceuticals, LTD
Electrical Impedence Myography
New Enrolling
Beth Israel Deaconess
Tretinoin and Pioglitazone HCL Combination Therapy
Now Enrolling
Phoenix Neurological Associates
Major Depression in ALS
Now Enrolling
University of South Carolina
AVP-923 in PBA Patients
Now Enrolling
Multi-center
Quality of Life Survey
Now Enrolling
Hershey ALS Clinic
Memantine Trial
Now Enrolling
University of Alberta
Trial for Familial ALS
Now Enrolling
Emory University
New Gene Study
Enrollment Open
Massachusetts General Hospital
Ceftriaxone
Now Enrolling
Northeast ALS Consortium
Memantine Therapy
Enrollment Closed
Banner Good Samaritan ALS Clinic
CLOSED TRIALS
Compound or Trial
Status
Company or Center
CL201 Study in ALS
Enrollment Closed
Multi-center
Tamoxifen
Enrollment Closed
The University of Wisconsin-Madison
Thalidomide
Enrollment Closed
Dartmouth-Hitchcock Medical Center
Diaphragm Training
Enrollment Closed
Beth Israel Deaconess Medical Center
National Registry of Veterans with ALS
Enrollment Closed
Durham, North Carolina VAMC
Combination TherapySelection Trial in ALS
Enrollment Closed
Multicenter
Sodium Phenylbutyrate
Enrollment Closed
Multicenter
The Vest
Enrollment Closed
Hill-Rom
Creatine
Enrollment Closed
The Carolinas Neuromuscular/ALS Center
Myotrophin®
Study Completed
Cephalon
Celebrex
Study Completed
Northeast ALS Consortium
NEOTROFINTM
Study Completed
NeoTherapeutics, Inc.
NAALADase
Study Completed
Guilford Pharmaceuticals Inc.
Neurodex
Study Completed
Avanir Pharmaceuticals
Rilutek®
FDA approved drug currently available
Aventis S.A.
Oxandrolone
Study Completed
The Carolinas Neuromuscular/ALS MDA Center
Pilot CoQ10
Enrollment Closed
Eleanor and Lou Gehrig ALS Center at Columbia University
High Dose Coenzyme Q10
Enrollment Closed
The Eleanor and Lou Gehrig MDA/ALS Research Center
Pilot CoQ10 with imaging
Enrollment Closed
Eleanor and Lou Gehrig ALS Center at Columbia University
Topiramate (Topamax)
Study Completed
North Eastern ALS Consortium
Xaliproden
Preliminary analysis released 9/5/00
Sanofi-Synthelabo Inc.
Indinavir
Study Completed
Beth Israel Medical Center
Creatine
Study Completed
North Eastern ALS Consortium
Creatine
Study Completed
The West Virginia University School of Medicine
Minocycline Investigation
Enrollment Closed
Eleanor and Lou Gehrig ALS Center at Columbia University
Buspirone Investigation
Study Completed
Multicenter ALS
Nessun commento:
Posta un commento